Northeast Financial Consultants’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,812
| Closed | -$445K | – | 359 |
|
|
2022
Q3 | $445K | Hold |
1,812
| – | – | 0.03% | 206 |
|
|
2022
Q2 | $448K | Hold |
1,812
| – | – | 0.03% | 205 |
|
|
2022
Q1 | $600K | Hold |
1,812
| – | – | 0.03% | 206 |
|
|
2021
Q4 | $651K | Hold |
1,812
| – | – | 0.04% | 192 |
|
|
2021
Q3 | $590K | Hold |
1,812
| – | – | 0.04% | 205 |
|
|
2021
Q2 | $566K | Hold |
1,812
| – | – | 0.04% | 209 |
|
|
2021
Q1 | $578K | Hold |
1,812
| – | – | 0.04% | 193 |
|
|
2020
Q4 | $587K | Sell |
1,812
-188
| -9% | -$60.9K | 0.05% | 179 |
|
|
2020
Q3 | $554K | Hold |
2,000
| – | – | 0.05% | 167 |
|
|
2020
Q2 | $483K | Hold |
2,000
| – | – | 0.05% | 174 |
|
|
2020
Q1 | $290K | Hold |
2,000
| – | – | 0.03% | 203 |
|
|
2019
Q4 | $341K | Hold |
2,000
| – | – | 0.03% | 220 |
|
|
2019
Q3 | $356K | Hold |
2,000
| – | – | 0.04% | 210 |
|
|
2019
Q2 | $521K | Hold |
2,000
| – | – | 0.05% | 181 |
|
|
2019
Q1 | $571K | Buy |
+2,000
| New | +$571K | 0.06% | 169 |
|